Cargando…

Characterizing the epithelial–mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma

BACKGROUND: Circulating tumor cells (CTCs), in particular those undergoing an epithelial–mesenchymal transition (EMT), are a promising source of biomarkers in head and neck squamous cell carcinoma (HNSCC). Our aim was to validate a protocol using microfluidic enrichment (Parsortix platform) with flo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Payne, Karl, Brooks, Jill, Batis, Nikolaos, Taylor, Graham, Nankivell, Paul, Mehanna, Hisham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804280/ https://www.ncbi.nlm.nih.gov/pubmed/35932094 http://dx.doi.org/10.1002/hed.27167

Ejemplares similares

Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Payne, Karl, et al.
Publicado: (2020)

Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects
por: Payne, Karl, et al.
Publicado: (2019)

Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping
por: Payne, Karl, et al.
Publicado: (2023)

Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery
por: Payne, Karl, et al.
Publicado: (2021)

Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation()
por: Batis, Nikolaos, et al.
Publicado: (2021)

Ultra-Low DNA Input into Whole Genome Methylation Assays and Detection of Oncogenic Methylation and Copy Number Variants in Circulating Tumour DNA
por: Whalley, Celina, et al.
Publicado: (2021)

Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma
por: Bryant, Jennifer, et al.
Publicado: (2019)

Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
por: Baumeister, Philipp, et al.
Publicado: (2021)

Epithelial–Mesenchymal Transition Associated with Head and Neck Squamous Cell Carcinomas: A Review
por: González-González, Rogelio, et al.
Publicado: (2021)

Evidence for Epithelial-Mesenchymal Transition in Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma
por: Chen, Chao, et al.
Publicado: (2011)

PLAU Promotes Cell Proliferation and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
por: Chen, Guangjin, et al.
Publicado: (2021)

Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma
por: Hollows, Robert, et al.
Publicado: (2018)

Markers of Epithelial to Mesenchymal Transition in Association with Survival in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Pectasides, Eirini, et al.
Publicado: (2014)

The Clinicopathological Significance of Epithelial Mesenchymal Transition Associated Protein Expression in Head and Neck Squamous Cell Carcinoma
por: Kim, Kyu Ho, et al.
Publicado: (2014)

DDB2 regulates Epithelial-to-Mesenchymal Transition (EMT) in Oral/Head and Neck Squamous Cell Carcinoma
por: Bommi, Prashant V., et al.
Publicado: (2018)

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
por: Ock, Chan-Young, et al.
Publicado: (2016)

UBE2O Promotes Progression and Epithelial–Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
por: Chen, Xiyu, et al.
Publicado: (2020)

Revised Modelling of the Addition of Synchronous Chemotherapy to Radiotherapy in Squamous Cell Carcinoma of the Head and Neck—A Low α/β?
por: Best, James, et al.
Publicado: (2018)

Epithelial-mesenchymal transition gene signature is associated with prognosis and tumor microenvironment in head and neck squamous cell carcinoma
por: Jung, Ah Ra, et al.
Publicado: (2020)

An Epithelial–Mesenchymal Transition Hallmark Gene-Based Risk Score System in Head and Neck Squamous-Cell Carcinoma
por: Liang, Feifei, et al.
Publicado: (2021)

Head and neck surgery recommendations during the COVID-19 pandemic – Author's reply
por: Mehanna, Hisham
Publicado: (2020)

Nicotine Promotes Acquisition of Stem Cell and Epithelial-to-Mesenchymal Properties in Head and Neck Squamous Cell Carcinoma
por: Yu, Michael Andrew, et al.
Publicado: (2012)

Overexpression of LIMA1 Indicates Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
por: Ma, Wei, et al.
Publicado: (2022)

Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
por: Brandt, Anna, et al.
Publicado: (2023)

Mitochondrial dysfunction and epithelial to mesenchymal transition in head neck cancer cell lines
por: Greier, Maria Carmo, et al.
Publicado: (2022)

Cultivation of Head and Neck Squamous Cell Carcinoma Cells with Wound Fluid Leads to Cisplatin Resistance via Epithelial-Mesenchymal Transition Induction
por: Meyer, Till Jasper, et al.
Publicado: (2021)

Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt
por: Kuo, Selena Z, et al.
Publicado: (2012)

Epithelial-Mesenchymal Transition Regulated by EphA2 Contributes to Vasculogenic Mimicry Formation of Head and Neck Squamous Cell Carcinoma
por: Wang, Wei, et al.
Publicado: (2014)

TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2018)

Verteporfin suppresses the proliferation, epithelial-mesenchymal transition and stemness of head and neck squamous carcinoma cells via inhibiting YAP1
por: Liu, Kui, et al.
Publicado: (2019)

The translational significance of epithelial-mesenchymal transition in head and neck cancer
por: Graves, Christian A, et al.
Publicado: (2014)

Epithelial-to-Mesenchymal Transition in the Pathogenesis and Therapy of Head and Neck Cancer
por: Thierauf, Julia, et al.
Publicado: (2017)

Circulating Tumor Cells Correlate With Prognosis in Head and Neck Squamous Cell Carcinoma
por: Zhou, Shichao, et al.
Publicado: (2021)

The Role of Exosomes in Epithelial–to-Mesenchymal Transition and Cell Functional Properties in Head and Neck Cancer
por: Mastronikolis, Nicholas S., et al.
Publicado: (2023)

Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial
por: Lorenc, A., et al.
Publicado: (2022)

Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients
por: Schrader, Carola H., et al.
Publicado: (2015)

Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties
por: Jung, Alain C., et al.
Publicado: (2015)

p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma
por: Wu, Dandan, et al.
Publicado: (2016)

CD200 Induces Epithelial-to-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma via β-Catenin-Mediated Nuclear Translocation
por: Shin, Seung-Phil, et al.
Publicado: (2019)

Grape seed proanthocyanidins inhibit the invasive potential of head and neck cutaneous squamous cell carcinoma cells by targeting EGFR expression and epithelial-to-mesenchymal transition
por: Sun, Qian, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hl93mekpdmufam6lkdlgm7kg0c